// App-Quantinova.ai

Mo1742 : Altered Prevalence of Circulating Novel Tc1, Tc17, Tcreg, and Double-Expressing CD8+ IFN-G+ IL-17+ T Cells in Inflammatory Bowel Disease Patients

Researchers

Presenter

  • Aito Ueno

Principal Investigators

  • Ronald Chan

  • Gilaad Kaplan

  • Vijay Yajnik

  • Subrata Ghosh

  • Daniel Hung

  • Ji Li

  • Kim Ford

  • Christina Hirota

  • Miriam Fort Gasia

  • Marietta Iacucci

  • Remo Panaccione

  • Paul L. Beck

Medical Centers

  • Massachusetts General Hospital, Boston, MA

  • University of Calgary, Calgary, AB, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

  • Crohn's disease

Biomarkers

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Interleukin 17A

  • Regulatory T cells

  • Type 1 T helper

Drug/Treatment

  • lonomycin

  • IFN-lambda

  • Mofezolac

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved